Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-25 @ 10:55 PM
Study NCT ID:
NCT00303667
Status:
COMPLETED
Last Update Posted:
2017-12-28
First Post:
2006-03-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant
Sponsor:
Masonic Cancer Center, University of Minnesota
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01
Start Date Type:
None
Primary Completion Date:
2011-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-03
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-15
First Submit QC Date:
None
Study First Post Date:
2006-03-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-06-11
Results First Submit QC Date:
None
Results First Post Date:
2015-07-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-03
Last Update Post Date:
2017-12-28
Last Update Post Date Type:
ACTUAL